Associate Professor James Wilmott

Associate Prof James Wilmott, Senior Scientist at the Melanoma Translational Research Laboratory, Melanoma Institute Australia.

I am a senior scientist in a translational research laboratory. In this role, I collaborate with clinical and patient groups to identify areas of need, discover solutions, and implement research to improve patient outcomes. I am passionate about applying clinicopathology, genomics, gene expression, and high-dimensional spatial pathology to develop tools for improved treatment selection and understanding of drug resistance.

 I am the principle investigator on the PIP-PREDICT, a multi-center, multicancer biomarker study applying multi-omic biomarker testing and reporting in oncology clinics.  This prospective study has enrolled and tested over 400 cancer patients in the past two years, delivering biomarker reports for discussion in multidisciplinary meetings